Indevus Pharmaceuticals (NasdaqNM:IDEV)

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Indevus Pharmaceuticals (NasdaqNM:IDEV)

An SI Board Since September 2003

Posts	SubjectMarks	Bans	Symbol
78	14	0	IDEV

Emcee: SemiBull	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
28	Rick, Peter often (most recently this weekend) cites you as having one of the mo	Harold Engstrom	-	8/30/2004
27	Don, I think IDEV has convertibles outstanding and as share price rises, I woul	Harold Engstrom	-	8/27/2004
26	I think that it means two things. The stock will go up or down. Shorts are stu	scaram(o)uche	-	8/27/2004
25	Well Richard, the short interest continues to rise as the news gets better. How	Don Hurst	-	8/27/2004
24	<pre>Month Short Interest Percent Change Average Daily Share Volume Days	scaram(o)uche	-	8/25/2004
23	Thanks ss and rkrw. That seems like a good royalty given the large upfront paym	Harold Engstrom	-	8/2/2004
22	Per the Madaus deal (sanctura licensor) Idev will owe Madaus 25% of the royalty.	rkrw	-	8/2/2004
21	IDEV IR says that it can be assumed that on 12/1 IDEV will exercise its right to	Sidney Street	-	8/2/2004
20	Sydney Street - do you know what ongoing royalty IDEV will receive for SANCTURA	Harold Engstrom	-	8/2/2004
19	Open label long term study: LEXINGTON, Mass., Jul 29, 2004 (BUSINESS WIRE) -- In	Sidney Street	-	7/29/2004
18	UPDATE 1-FDA approves Indevus's overactive bladder drug May 28, 2004 1:02:00	Greg Rich	-	5/28/2004
17	<looking at IDEV> A few comments on the Biotech Valuation board: Message	Sidney Street	-	4/25/2004
16	<i>anyone still looking at IDEV?</i> While I have been swamped with	SemiBull	-	4/25/2004
15	anyone still looking at IDEV? Another poster on the Yahoo IMM board showed it t	flushbusted	-	4/20/2004
14	Incara and Indevus Outlicense Bucindolol Interest for Development Friday Novemb	SemiBull	-	1/4/2004
13	marketwatch.com	MKTBUZZ	-	12/18/2003
12	fiscal 2003 results out. there's a lot to like here. strong cash position a	tom r. phillips	-	12/18/2003
11	...and a marketing partner for Trospium.	Sergio H	-	10/29/2003
10	Thanks SB. It's my understanding that IDEV is pursuing a worldwide developme	Sergio H	-	10/27/2003
9	<i>Is IDEV expected to announce a marketing agreement around this time? TI	SemiBull	-	10/26/2003
8	Hi SemiBull. Is IDEV expected to announce a marketing agreement around this time	Sergio H	-	10/20/2003
7	Early Patient Response Predicts Long-Term Success of Therapy With Indevus' T	SemiBull	-	10/14/2003
6	Presentations at International Continence Society Highlight Onset of Action, Uro	SemiBull	-	10/9/2003
5	Indevus' Trospium Shown to Reduce Urgency Severity Among Patients with Over	SemiBull	-	10/7/2003
4	Enablex, Novartis' Novel M3 Antagonist for Overactive Bladder, On Track for	SemiBull	-	10/3/2003

Go to reply# or date (mm/dd/yy):